3 results
Approved WMORecruiting
To explore the efficacy and safety of an oral IP receptor agonist in an inoperable or persistent/recurrent CTEPH population treated with standard of care.
Approved WMORecruiting
Primary objective:To evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discontinuation of feeder studies in participants who had previously received aducanumab (i.e., previously treated…
Approved WMORecruiting
The objective of the clinical investigation is to evaluate the safety and performance of the Artimis* medial meniscus prosthesis system and to demonstrate that the Artimis* medial meniscus prosthesis is able to restore the function of the natural…